Oseltamivir Phosphate
NDC Package 69539-109-33

11-digit billing NDC: 69539010933

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Oseltamivir Phosphate is contraindicated in patients with known serious hypersensitivity to oseltamivir or any component of the product. Marketed by Msn Laboratories Private Limited, this product is identified by NDC 69539-109 and is authorized under FDA application ANDA212544.

Identification & Billing

NDC Package Code
69539-109-33
Package Description
1 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK (69539-109-11)
Product Code
11-Digit Billing Format
69539010933
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Oseltamivir Phosphate
Dosage Form
-
Usage Information
Oseltamivir phosphate is contraindicated in patients with known serious hypersensitivity to oseltamivir or any component of the product. Severe allergic reactions have included anaphylaxis and serious skin reactions including toxic epidermal necrolysis, Stevens-Johnson Syndrome, and erythema multiforme [see Warnings and Precautions (5.1)].

Regulatory & Marketing

Labeler Name
Msn Laboratories Private Limited
FDA Application #
ANDA212544
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-22-2020
End Marketing Date
11-21-2025
Listing Expiration
11-21-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69539-109-33 identifies a specific commercial package of 1 blister pack in 1 carton / 10 capsule in 1 blister pack (69539-109-11) of Oseltamivir Phosphate, labeled by Msn Laboratories Private Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Msn Laboratories Private Limited on May 22, 2020. The current certification is valid through November 21, 2025.

How is this Msn Laboratories Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69539010933. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69539-109-33
11-Digit CMS (5-4-2)
69539-0109-33

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.